Bad luck

after four years of waiting for the drug, Exondys wasn´t approved in Europe

and the worst thing is that, the hope for everyone with Duchenne disease in the Ezutromid trial is over

EZUTROMID

let's hope that the road to approval in Europe will not be as long as it is for Exondys 51

https://musculardystrophynews.com/2018/01/26/ezutromid-reduced-muscle-damage-in-dmd-patients-interim-data-shows/

snad cesta ke schválení v Evropě nebude tak dlouhá jako u Exondys 51

http://www.parentproject.cz/prispevky/ezutromid